SCHEMBL4596683

SCHEMBL4596683

[CH2]C1Cc2cc(C(F)(F)F)cc(-c3ccc(C)cc3)c2O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
KDM1A O60341 1/20 0.34
DRD2 P14416 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
NPBWR1 P48145 1/20 0.32
APOB P04114 1/20 0.31
MTTP P55157 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4595686 0.90 DRD2 (0.38) MAOAMAOBDRD2
SCHEMBL4597024 0.88 PTGS1 (0.34) PTGS1PTGS2MAOAMAOBDRD2
SCHEMBL4596686 0.86 MAOA (0.42) PTGS1PTGS2MAOAMAOBKDM1A
SCHEMBL4596880 0.86 PTGS1 (0.37) PTGS1PTGS2DRD2PDE3BPDE3A
SCHEMBL4596474 0.86 PTGDR2 (0.40) PTGS1PTGS2MAOBDRD2MAPT
SCHEMBL4712619 0.86 HTR1A (0.36) MAOAMAOBDRD2GABRPGABRD
SCHEMBL4596756 0.84 MAOB (0.34) PTGS1PTGS2MAOAMAOBMAPT
SCHEMBL4596739 0.83 AQP1 (0.38) PTGS1PTGS2MAOAMAOBMAPT
SCHEMBL4597183 0.83 PRKAB2 (0.34) PTGS1PTGS2PDE3BPDE3A
SCHEMBL4232604 0.82 PRKAB2 (0.45) PTGS1PTGS2MAOAMAOBKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
EP-1871355-A1 NEW THERAPEUTIC COMBIANATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION Wyeth (US) 2008-01-02 EP disclosed
EP-1871354-A1 TREATMENT OF PAIN Wyeth (US) 2008-01-02 EP disclosed
WO-2007030150-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH (US) 2007-03-15 WO disclosed
WO-2006116149-A1 NEW THERAPEUTIC COMBIANATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION WYETH (US) 2006-11-02 WO disclosed
WO-2006116171-A1 TREATMENT OF PAIN WYETH (US) 2006-11-02 WO disclosed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP disclosed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO disclosed